[{"NetIncomeLoss_1_Q1_USD":-47104000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":50000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-5276000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":4449000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":17216000.0,"AssetsCurrent_0_Q1_USD":433117000.0,"OperatingLeaseExpense_1_Q1_USD":1500000.0,"LongTermDebtCurrent_0_Q1_USD":5625000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":163434000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":66200000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":1272000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":13308000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-99000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":453185000.0,"Assets_0_Q1_USD":577062000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-99000.0,"ShareBasedCompensation_1_Q1_USD":5261000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":79687000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":27430000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":14806000.0,"LongTermDebtFairValue_0_Q1_USD":46500000.0,"CommitmentsAndContingencies_0_Q1_USD":0.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":64250000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-3120000.0,"AccountsReceivableNetCurrent_0_Q1_USD":4514000.0,"CommonStockValue_0_Q1_USD":71000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":18249000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":537000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-3596000.0,"DeferredRevenueNoncurrent_0_Q1_USD":87000000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q1_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-47203000.0,"OtherAssetsNoncurrent_0_Q1_USD":6396000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":44594000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":85633000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1107135000.0,"Liabilities_0_Q1_USD":509216000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":3596000.0,"OperatingLeaseLiability_0_Q1_USD":90928000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":15598000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":71195.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ConvertibleDebtFairValueDisclosures_0_Q1_USD":338800000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":141624000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"AmortizationOfFinancingCosts_1_Q1_USD":27000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5261000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-29519000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1_Q1_USD":3300000.0,"LiabilitiesCurrent_0_Q1_USD":35930000.0,"AccountsPayableCurrent_0_Q1_USD":7766000.0,"NonoperatingIncomeExpense_1_Q1_USD":290000.0,"InterestExpense_1_Q1_USD":3988000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":3026000.0,"LongTermDebtNoncurrent_0_Q1_USD":40874000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":2243000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.098,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":44594000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q1_USD":0.0,"OperatingLeasePayments_1_Q1_USD":1100000.0,"DebtSecuritiesAvailableForSaleGainLoss_1_Q1_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":3763000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":23198000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":94000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":232552000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-38391000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":6626000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":17668000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-2677000.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":-4047000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":6548000.0,"OperatingIncomeLoss_1_Q1_USD":-40611000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":380983000.0,"AvailableForSaleSecuritiesNoncurrent_0_Q1_USD":34664000.0,"InvestmentIncomeInterest_1_Q1_USD":300000.0,"PreferredStockValue_0_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":577062000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":6987000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":5295000.0,"OperatingExpenses_1_Q1_USD":47159000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":77887000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.66,"ProfitLoss_1_Q1_USD":-47104000.0,"OtherLiabilitiesCurrent_0_Q1_USD":2438000.0,"StockholdersEquity_0_Q1_USD":67846000.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q1_USD":2677000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1039410000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":31561000.0,"Ticker":"CYTK","CIK":"1061983","name":"CYTOKINETICS INC","OfficialName":"Cytokinetics Incorporated Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3243164482.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210507"}]